BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 13499)

  • 1. Dopamine-sensitive adenylate cyclase: location in substantia nigra.
    Gale K; Guidotti A; Costa E
    Science; 1977 Feb; 195(4277):503-5. PubMed ID: 13499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.
    Saavedra JM; Setler PE; Kebabian JW
    Brain Res; 1978 Aug; 151(2):339-52. PubMed ID: 679013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum.
    Spano PF; Trabucchi M; Di Chiara G
    Science; 1977 Jun; 196(4296):1343-5. PubMed ID: 17159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence concerning the anatomical location of the dopamine stimulated adenylate cyclase in the substantia nigra.
    Phillipson OT; Emson PC; Horn AS; Jessell T
    Brain Res; 1977 Nov; 136(1):45-58. PubMed ID: 22389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-sensitive adenylate cyclase and cAMP phosphodiesterase in substantia nigra and corpus striatum of rat brain.
    Traficante LJ; Friedman E; Oleshansky MA; Gershon S
    Life Sci; 1976 Oct; 19(7):1061-6. PubMed ID: 186677
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites.
    Kebabian JW; Saavedra JM
    Science; 1976 Aug; 193(4254):683-5. PubMed ID: 181842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic localization of substance P degradative enzymes(s) in rat substantia nigra.
    Quik M; Emson PC
    Neurosci Lett; 1979 Dec; 15(2-3):217-22. PubMed ID: 93730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat.
    Schwarcz R; Coyle JT
    Life Sci; 1977 Feb; 20(3):431-6. PubMed ID: 14287
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
    Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase.
    Phillipson OT; Horn AS
    Nature; 1976 Jun; 261(5559):418-20. PubMed ID: 934274
    [No Abstract]   [Full Text] [Related]  

  • 13. Fetal substantia nigra grafts. Effect on dopamine receptors in the rat corpus striatium.
    Korfali E; Knowles WD; Uysal S; Ulus IH; Ozmen T
    Cleve Clin J Med; 1989 May; 56(3):259-62. PubMed ID: 2568188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
    Seeber U; Kuschinsky K
    Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'?
    Premont J; Thierry AM; Tassin JP; Glowinski J; Blanc G; Bockaert J
    FEBS Lett; 1976 Sep; 68(1):99-104. PubMed ID: 964385
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of kainic acid in the localization of enzymes in the substantia nigra.
    Nagy JI; Vincent SR; Lehmann J; Fibiger HC; McGeer EG
    Brain Res; 1978 Jun; 149(2):431-41. PubMed ID: 27284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
    Abbracchio MP; Colombo F; Di Luca M; Zaratin P; Cattabeni F
    Pharmacol Res Commun; 1987 Apr; 19(4):275-86. PubMed ID: 2889222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations.
    Markstein R; Stöckli KA; Reubi JC
    Neurosci Lett; 1989 Sep; 104(1-2):13-8. PubMed ID: 2573010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.